Surgery and OncologySurgery and OncologyХирургия и онкология2949-5857Publishing House ABV Press8710.17650/2220-3478-2014-0-4-92-101CASE REPORTКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯSPHINCTER-SPARING TREATMENT FOR A GASTROINTESTINAL STROMAL TUMOR OF THE LOWER RECTAL AMPULLA: A CLINICAL CASEСФИНКТЕРОСОХРАНЯЮЩЕЕ ЛЕЧЕНИЕ ГАСТРОИНТЕСТИНАЛЬНОЙ СТРОМАЛЬНОЙ ОПУХОЛИ ПРЯМОЙ КИШКИ НИЖНЕАМПУЛЯРНОЙ ЛОКАЛИЗАЦИИ: КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕBarsukovYu. A.БарсуковЮ. А.
Russian Federation
rasim-t@mail.ruTamrazovR. I.ТамразовР. И.
Russian Federation
rasim-t@mail.ruMadyarovZh. M.МадьяровЖ. М.
Russian Federation
rasim-t@mail.ruGordeyevS. S.ГордеевС. С.
Russian Federation
rasim-t@mail.ruKuzmichevD. V.КузьмичевД. В.
Russian Federation
rasim-t@mail.ruKulushevV. M.КулушевВ. М.
Russian Federation
rasim-t@mail.ruDzhumabayevKh. E.ДжумабаевХ. Э.
Russian Federation
rasim-t@mail.ruN.N. Blokhin Russian Cancer Research Center, MoscowФГБНУ «РОНЦ им. Н.Н. Блохина», Москва281220143432380103201501032015Copyright ©; 2014, Barsukov Y.A., Tamrazov R.I., Madyarov Z.M., Gordeyev S.S., Kuzmichev D.V., Kulushev V.M., Dzhumabayev K.E.Copyright ©; 2014, Барсуков Ю.А., Тамразов Р.И., Мадьяров Ж.М., Гордеев С.С., Кузьмичев Д.В., Кулушев В.М., Джумабаев Х.Э.2014Barsukov Y.A., Tamrazov R.I., Madyarov Z.M., Gordeyev S.S., Kuzmichev D.V., Kulushev V.M., Dzhumabayev K.E.Барсуков Ю.А., Тамразов Р.И., Мадьяров Ж.М., Гордеев С.С., Кузьмичев Д.В., Кулушев В.М., Джумабаев Х.Э.https://creativecommons.org/licenses/by/4.0https://onco-surgery.info/jour/article/view/87

The article describes statistics, issues of diagnosis and treatment of rare type of tumors – gastrointestinal stromal tumor. Presented case report of the patient with this tumor in low rectum, which was treated with sphincter saving operation. Also shows the possibility of postoperative morphological diagnosis.

В статье отражена статистика, вопросы диагностики и лечения крайне редкой нозологической формы – гастроинтестинальной стромальной опухоли прямой кишки. Представлено клиническое наблюдение пациента с данной патологией, которому была выполнена сфинктеросохраняющая операция при нижнеампулярной локализации процесса, а также возможности послеоперационной морфологической диагностики.

gastrointestinal stromal tumorsphincter-preserving surgeryimmunohistochemical studyгастроинтестинальная стромальная опухольсфинктеросохраняющие операциииммуногистохимическое исследование1. Никулин М.П., Стилиди И.С. Гастроинтестинальные стромальные опухоли (ГИСО). Эпидемиология, диагностика, современные подходы к лечению. Современная онкология. Экстра-выпуск 2007. С. 3–50.Никулин М.П., Стилиди И.С. Гастроинтестинальные стромальные опухоли (ГИСО). Эпидемиология, диагностика, современные подходы к лечению. Современная онкология. Экстра-выпуск 2007. С. 3–50.2. Гастроинтестинальные стромальные опухоли (диагностика, лечение). Практические рекомендации. М., 2008. 53 с.Гастроинтестинальные стромальные опухоли (диагностика, лечение). Практические рекомендации. М., 2008. 53 с.3. Kim C.J., Day S., Yeh K.A. Gastrointestinal stromal tumors: analysis of clinical and pathologic factors. Am Surg 2001;67(2):135–7.Kim C.J., Day S., Yeh K.A. Gastrointestinal stromal tumors: analysis of clinical and pathologic factors. Am Surg 2001;67(2):135–7.4. Steigen S.E., Eide T.J. Gastrointestinal stromal tumors (GISTs): a review. APMIS 2009;117(2):73–86.Steigen S.E., Eide T.J. Gastrointestinal stromal tumors (GISTs): a review. APMIS 2009;117(2):73–86.5. Mazur M.T., Clark H.B. Gastric stromal tumours. Reappraisal of histogenesis. Am J Surg Pathol 1983;7(6):507–19.Mazur M.T., Clark H.B. Gastric stromal tumours. Reappraisal of histogenesis. Am J Surg Pathol 1983;7(6):507–19.6. Cajal S.R. (1888). Estructura del centro nervioso de las aves. Rev Trimes Hist Norm y Patol;1:1–10.Cajal S.R. (1888). Estructura del centro nervioso de las aves. Rev Trimes Hist Norm y Patol;1:1–10.7. Стромальные опухоли желудочно-кишечного тракта (GIST): Клиническая монография. Тверь: ООО «Издательство «Триада», 2006.Стромальные опухоли желудочно-кишечного тракта (GIST): Клиническая монография. Тверь: ООО «Издательство «Триада», 2006.8. Majumder S., Brown K., Qiu F.H., Besmer P. C-kit protein, a transmembrane kinase: identification in tissues and characterization. Mol Cell Biol 1988;8(11): 4896–903.Majumder S., Brown K., Qiu F.H., Besmer P. C-kit protein, a transmembrane kinase: identification in tissues and characterization. Mol Cell Biol 1988;8(11): 4896–903.9. Burkill G.J., Badran M., Al-Muderis O. et al. Malignant gastrointestinal stromal tumors: distribution, imaging, features, and pattern of metastatic spread. Radiology 2003;22(6):527–32.Burkill G.J., Badran M., Al-Muderis O. et al. Malignant gastrointestinal stromal tumors: distribution, imaging, features, and pattern of metastatic spread. Radiology 2003;22(6):527–32.10. Hirota S., Isozaki K., Moriyama Y. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998 Jan 23;279(5350):577–80.Hirota S., Isozaki K., Moriyama Y. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998 Jan 23;279(5350):577–80.11. Sarlomo-Rikala M., Kovatich A.J., Barusevicius A., Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11(8):728–34.Sarlomo-Rikala M., Kovatich A.J., Barusevicius A., Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11(8):728–34.12. Miettinen M., Majiadi M., Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. EJС 2002;38(5):39–50.Miettinen M., Majiadi M., Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. EJС 2002;38(5):39–50.13. Demetri G.D. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Semin Oncol 2001;28(17):19–26.Demetri G.D. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Semin Oncol 2001;28(17):19–26.14. Nishida T., Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000;15(4):1293–301.Nishida T., Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000;15(4):1293–301.15. Анурова О.А. Морфологическая и иммуногистохимическая диагностика гастроинтестинальных опухолей ЖКТ. Современная онкология. Экстра-выпуск 2007. С. 79–99.Анурова О.А. Морфологическая и иммуногистохимическая диагностика гастроинтестинальных опухолей ЖКТ. Современная онкология. Экстра-выпуск 2007. С. 79–99.16. Беляков И.С., Анурова О.А., Снигур П.В. и др. Мутации генов c-Kit и PDGFRA и клинико-морфологические особенности стромальных опухолей желудочно-кишечного тракта. Вопросы онкологии 2007;53(6):677–81.Беляков И.С., Анурова О.А., Снигур П.В. и др. Мутации генов c-Kit и PDGFRA и клинико-морфологические особенности стромальных опухолей желудочно-кишечного тракта. Вопросы онкологии 2007;53(6):677–81.17. Снигур П.В., Анурова О.А., Петровичев Н.Н., Сельчук В.Ю. Клинико-морфологические особенности стромальных опухолей ЖКТ. Вопросы онкологии 2003;49(6):705–10.Снигур П.В., Анурова О.А., Петровичев Н.Н., Сельчук В.Ю. Клинико-морфологические особенности стромальных опухолей ЖКТ. Вопросы онкологии 2003;49(6):705–10.18. Miettinen M., El-Rifal W., Sobin L. et al. Human Pathology 2002;33(5):478–83.Miettinen M., El-Rifal W., Sobin L. et al. Human Pathology 2002;33(5):478–83.19. Fletcher C.D., Berman J.J., Corless C. et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002 May;33(5):459–65.Fletcher C.D., Berman J.J., Corless C. et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002 May;33(5):459–65.20. Казанцева И.А. Морфологические особенности ГИСО. Современная онкология. Экстра-выпуск 2007. С. 50–79.Казанцева И.А. Морфологические особенности ГИСО. Современная онкология. Экстра-выпуск 2007. С. 50–79.21. Pierie J.P., Choudry U., Muzikansky A. et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136(4):383–9.Pierie J.P., Choudry U., Muzikansky A. et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136(4):383–9.22. Архири П.П. Хирургическое лечение и факторы прогноза у больных стромальными опухолями желудочно-кишечного тракта. Автореф. дис. … канд. мед. наук. М., 2010.Архири П.П. Хирургическое лечение и факторы прогноза у больных стромальными опухолями желудочно-кишечного тракта. Автореф. дис. … канд. мед. наук. М., 2010.23. Ray-Coquard I., Le Cesne A., Michallet V. et al. Gastrointestinal stromal tumors: news and comments. Bull Cancer 2003;90(1): 69–76.Ray-Coquard I., Le Cesne A., Michallet V. et al. Gastrointestinal stromal tumors: news and comments. Bull Cancer 2003;90(1): 69–76.24. Liu H., Yan Z., Liao G., Yin H. Treatment strategy of rectal gastrointestinal stromal tumor (GIST). J Surg Oncol 2014 Jun;109(7):708–13.Liu H., Yan Z., Liao G., Yin H. Treatment strategy of rectal gastrointestinal stromal tumor (GIST). J Surg Oncol 2014 Jun;109(7):708–13.25. Joensuu H., Fletcher С., Dimitrijevic S. et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002;3(11):655–64.Joensuu H., Fletcher С., Dimitrijevic S. et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002;3(11):655–64.26. DeMatteo R.P., Ballman K.V., Antonescu C.R. et al.; the American College of Surgeons Oncology Group (ACOSOG). Adjuvant imatinib mesylate following the resection of localized, primary gastrointestinal stromal tumor: a randomised, double-blind, placebo-controlled trial. Lancet 2009;373(9669):1097–104.DeMatteo R.P., Ballman K.V., Antonescu C.R. et al.; the American College of Surgeons Oncology Group (ACOSOG). Adjuvant imatinib mesylate following the resection of localized, primary gastrointestinal stromal tumor: a randomised, double-blind, placebo-controlled trial. Lancet 2009;373(9669):1097–104.27. Blackstein M.E., Blay J.Y., Corless C. et al.; Canadian Advisory Committee on GIST. Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. Can J Gastroenterol 2006;20(3):157–63.Blackstein M.E., Blay J.Y., Corless C. et al.; Canadian Advisory Committee on GIST. Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. Can J Gastroenterol 2006;20(3):157–63.28. Demetri G., von Mehren M., Blanke C. et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347(7):472–80.Demetri G., von Mehren M., Blanke C. et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347(7):472–80.29. Dagher R., Cohen M., Williams G. et al. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 2002;8(10):3034–8.Dagher R., Cohen M., Williams G. et al. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 2002;8(10):3034–8.30. Demetri G.D., van Oosterom A.T., Garrett C.R. et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 2006;368:1329–38.Demetri G.D., van Oosterom A.T., Garrett C.R. et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 2006;368:1329–38.31. Blay J.Y., Bonvalot S., Casali P. et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 2005;16:566–78.Blay J.Y., Bonvalot S., Casali P. et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 2005;16:566–78.32. Benjamin R., Rankin C., Fletcher C. et al. Phase III dose-randomized study of imatinib mesylate (STI571) for GIST: intergroup S0033 early results. Proc Am Soc Clin Oncol 2003;22:3271.Benjamin R., Rankin C., Fletcher C. et al. Phase III dose-randomized study of imatinib mesylate (STI571) for GIST: intergroup S0033 early results. Proc Am Soc Clin Oncol 2003;22:3271.33. Demetri G., Benjamin R., Blanke C.D. et al. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines. J Natl Compr Canc Netw 2004;2 (suppl 1):1–26.Demetri G., Benjamin R., Blanke C.D. et al. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines. J Natl Compr Canc Netw 2004;2 (suppl 1):1–26.34. D'Amato G., Steinert D.M., McAuliffe J.C., Trent J.C. Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control 2005 Jan-Feb;12(1): 44–56.D'Amato G., Steinert D.M., McAuliffe J.C., Trent J.C. Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control 2005 Jan-Feb;12(1): 44–56.35. Fujimoto Y., Akiyoshi T., Konishi T. et al. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis 2014 Jan;29(1):111–6.Fujimoto Y., Akiyoshi T., Konishi T. et al. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis 2014 Jan;29(1):111–6.36. Centonze D., Pulvirenti E., Pulvirenti D'Urso A. et al. Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors. Tech Coloproctol 2013 Oct;17(5): 571–4.Centonze D., Pulvirenti E., Pulvirenti D'Urso A. et al. Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors. Tech Coloproctol 2013 Oct;17(5): 571–4.